A widely prescribed drug, simvastatin, can help patients with secondary progressive Multiple Sclerosis - for reasons that might be unrelated to the drug’s intended cholesterol lowering affects, finds a study led by Dr Arman Eshaghi (UCL Queen Square Institute of Neurology).
Read: Telegraph, More: UCL News
Close
